WorldPharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal Last updated: July 29, 2025 3:18 pm TARESH SINGH Share 0 Min Read SHARE The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.Related European stocks set to open higher as investors digest earnings season China begins building world’s largest dam, fuelling fears in India Magnitude 8.6 earthquake strikes off Russia’s Kamchatka, sparks tsunami warnings, USGS says China’s Laopu Gold shares fall despite forecast of tripling profits Divided Fed holds key interest rate steady, defying Trump’s demands for aggressive cuts Share This Article Facebook Pinterest Whatsapp Whatsapp LinkedIn Telegram Threads Copy Link Print Share Previous Article Sanjay Dutt’s first look from ‘The Raja Saab’ out Next Article How to properly water and care for your plants before leaving for a vacation Leave a Comment Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment *Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Latest News Meta’s big AI spending blitz will continue into 2026 World July 31, 2025 ‘How do you plan to hold Senthil trial,’ SC asks Tamil Nadu July 31, 2025 Microsoft’s monster quarter and strong outlook cements its status as an AI leader Technology July 31, 2025 ‘Kingdom’ Movie Review and Release Live Updates Entertainment July 31, 2025 Google news feed
